Cardiac transplantation in adult congenital heart disease with prior sternotomy.
Journal
Clinical transplantation
ISSN: 1399-0012
Titre abrégé: Clin Transplant
Pays: Denmark
ID NLM: 8710240
Informations de publication
Date de publication:
04 2021
04 2021
Historique:
revised:
10
01
2021
received:
17
09
2020
accepted:
12
01
2021
pubmed:
22
1
2021
medline:
3
7
2021
entrez:
21
1
2021
Statut:
ppublish
Résumé
Adult congenital heart disease (ACHD) patients who require orthotopic heart transplantation are surgically complex due to anatomical abnormalities and multiple prior surgeries. In this study, we investigated these patients' outcomes using our institutional database. ACHD patients who had prior intracardiac repair and subsequent heart transplant were included (2008-2018). Adult patients without ACHD were extracted as a control. A comparison of patients with functional single ventricular (SV) and biventricular (BV) hearts was performed. There were 9 SV and 24 BV patients. The SV group had higher central venous pressure/pulmonary capillary wedge pressure (P = .028), hemoglobin concentration (P = .010), alkaline phosphatase (P = .022), and were more likely to have liver congestion (P = .006). Major complications included infection in 16 (48.5%), temporary dialysis in 12 (36.4%), and graft dysfunction requiring perioperative mechanical support in 7 (21.2%). Overall in-hospital mortality was 15.2%. Kaplan-Meier analysis showed a higher, but not statistically significant, survival after 10 years between the ACHD and control groups (ACHD 84.9% vs. control 67.5%, P = .429). There was no significant difference in 10-year survival between SV and BV groups (78% vs. 88%, P = .467). Complex ACHD cardiac transplant recipients have a high incidence of early morbidities after transplantation. However, long-term outcomes were acceptable.
Sections du résumé
BACKGROUND
Adult congenital heart disease (ACHD) patients who require orthotopic heart transplantation are surgically complex due to anatomical abnormalities and multiple prior surgeries. In this study, we investigated these patients' outcomes using our institutional database.
METHODS
ACHD patients who had prior intracardiac repair and subsequent heart transplant were included (2008-2018). Adult patients without ACHD were extracted as a control. A comparison of patients with functional single ventricular (SV) and biventricular (BV) hearts was performed.
RESULTS
There were 9 SV and 24 BV patients. The SV group had higher central venous pressure/pulmonary capillary wedge pressure (P = .028), hemoglobin concentration (P = .010), alkaline phosphatase (P = .022), and were more likely to have liver congestion (P = .006). Major complications included infection in 16 (48.5%), temporary dialysis in 12 (36.4%), and graft dysfunction requiring perioperative mechanical support in 7 (21.2%). Overall in-hospital mortality was 15.2%. Kaplan-Meier analysis showed a higher, but not statistically significant, survival after 10 years between the ACHD and control groups (ACHD 84.9% vs. control 67.5%, P = .429). There was no significant difference in 10-year survival between SV and BV groups (78% vs. 88%, P = .467).
CONCLUSIONS
Complex ACHD cardiac transplant recipients have a high incidence of early morbidities after transplantation. However, long-term outcomes were acceptable.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e14229Informations de copyright
© 2021 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.
Références
Marelli AJ, Ionescu-Ittu R, Mackie AS, Guo L, Dendukuri N, Kaouache M. Lifetime prevalence of congenital heart disease in the general population from 2000 to 2010. Circulation. 2014;130:749-756.
Hernandez GA, Lemor A, Clark D, et al. Heart transplantation and in-hospital outcomes in adult congenital heart disease patients with Fontan: a decade nationwide analysis from 2004 to 2014. J Card Surg. 2004;2020(35):603-608.
Gilboa SM, Devine OJ, Kucik JE, et al. Congenital heart defects in the united states: estimating the magnitude of the affected population in 2010. Circulation. 2016;134:101-109.
Maxwell BG, Wong JK, Sheikh AY, Lee PH, Lobato RL. Heart transplantation with or without prior mechanical circulatory support in adults with congenital heart disease. Eur J Cardiothorac Surg. 2014;45:842-846.
Burchill LJ. Heart transplantation in adult congenital heart disease. Heart. 2016;102:1871-1877.
Kainuma A, Sanchez J, Ning Y, et al. Outcomes of heart transplantation in adult congenital heart disease with prior intracardiac repair. Ann Thorac Surg. 2020;16:S0003. https://doi.org/10.1016/j.athoracsur.2020.06.116
Bryant R 3rd, Morales D. Overview of adult congenital heart transplants. Ann Cardiothorac Surg. 2018;7:143-151.
Houyel L, To-Dumortier NT, Lepers Y, et al. Heart transplantation in adults with congenital heart disease. Arch Cardiovasc Dis. 2017;110:346-353.
Davies RR, Russo MJ, Yang J, Quaegebeur JM, Mosca RS, Chen JM. Listing and transplanting adults with congenital heart disease. Circulation. 2011;123:759-767.
Kansara P, Czer L, Awad M, et al. Heart transplantation with and without prior sternotomy: analysis of the United Network for Organ Sharing database. Transplant Proc. 2014;46:249-255.
Shah DK, Deo SV, Althouse AD, et al. Perioperative mortality is the Achilles heel for cardiac transplantation in adults with congenital heart disease: evidence from analysis of the UNOS registry. J Card Surg. 2016;31:755-764.
Patel ND, Weiss ES, Allen JG, et al. Heart transplantation for adults with congenital heart disease: analysis of the United network for organ sharing database. Ann Thorac Surg. 2009;88:814-822.
Riggs KW, Zafar F, Radzi Y, Yu PJ, Bryant R 3rd, Morales DLS. Adult congenital heart disease: current early expectations after cardiac transplantation. Ann Thorac Surg. 2020;109:480-486.
Kavarana MN, Savage A, O'Connell R, et al. Composite risk factors predict survival after transplantation for congenital heart disease. J Thorac Cardiovasc Surg. 2013;146:888-893.
Cohen S, Houyel L, Guillemain R, et al. Temporal trends and changing profile of adults with congenital heart disease undergoing heart transplantation. Eur Heart J. 2016;37:783-789.
Crossland DS, Jansen K, Parry G, et al. Outcome following heart transplant assessment in adults with congenital heart disease. Heart. 2019;105:1741-1747.
Lewis M, Ginns J, Schulze C, et al. Outcomes of adult patients with congenital heart disease after heart transplantation: impact of disease type, previous thoracic surgeries, and bystander organ dysfunction. J Card Fail. 2016;22:578-582.
Menachem JN, Schlendorf KH, Mazurek JA, et al. Advanced heart failure in adults with congenital heart disease. JACC Heart Fail. 2020;8:87-99.
Horvath KA, Acker MA, Chang H, et al. Blood transfusion and infection after cardiac surgery. Ann Thorac Surg. 2013;95:2194-2201.
Davies RR, Sorabella RA, Yang J, Mosca RS, Chen JM, Quaegebeur JM. Outcomes after transplantation for "failed" Fontan: a single-institution experience. J Thorac Cardiovasc Surg. 2012;143:1183-1192.
Simpson KE, Esmaeeli A, Khanna G, et al. Liver cirrhosis in Fontan patients does not affect 1-year post-heart transplant mortality or markers of liver function. J Heart Lung Transplant. 2014;33:170-177.
Atluri P, Gaffey A, Howard J, et al. Combined heart and liver transplantation can be safely performed with excellent short- and long-term results. Ann Thorac Surg. 2014;98:858-862.
Pal N, Stansfield J, Mukhopadhyay N, Nelson M. Marginal Improvement in survival post-heart transplantation in patients with prior left ventricular assist device: a temporal analysis of united network of organ sharing registry. J Cardiothorac Vasc Anesth. 2020;34:392-400.
Everitt MD, Donaldson AE, Stehlik J, et al. Would access to device therapies improve transplant outcomes for adults with congenital heart disease? Analysis of the United Network for Organ Sharing (UNOS). J Heart Lung Transplant. 2011;30:395-401.
VanderPluym CJ, Cedars A, Eghtesady P, et al. Outcomes following implantation of mechanical circulatory support in adults with congenital heart disease: an analysis of the interagency registry for mechanically assisted circulatory support (INTERMACS). J Heart Lung Transplant. 2018;37:89-99.
Russo MJ, Iribarne A, Hong KN, et al. Factors associated with primary graft failure after heart transplantation. Transplantation. 2010;90:444-450.
D'Alessandro C, Golmard JL, Barreda E, et al. Predictive risk factors for primary graft failure requiring temporary extra-corporeal membrane oxygenation support after cardiac transplantation in adults. Eur J Cardiothorac Surg. 2011;40:962-969.
Still S, Shaikh AF, Qin H, et al. Reoperative sternotomy is associated with primary graft dysfunction following heart transplantation. Interact Cardiovasc Thorac Surg. 2018;27:343-349.
Iyer A, Kumarasinghe G, Hicks M, et al. Primary graft failure after heart transplantation. J Transplant. 2011;2011:175768. https://doi.org/10.1155/2011/175768
Haddad F, Deuse T, Pham M, et al. Changing trends in infectious disease in heart transplantation. J Heart Lung Transplant. 2010;29:306-315.
Givertz MM, DeFilippis EM, Landzberg MJ, Pinney SP, Woods RK, Valente AM. Advanced heart failure therapies for adults with congenital heart disease: JACC state-of-the-art review. J Am Coll Cardiol. 2019;74:2295-2312.
Hörer J. Current spectrum, challenges and new developments in the surgical care of adults with congenital heart disease. Cardiovasc Diagn Ther. 2018;8:754-764.
Oster ME, Knight JH, Suthar D, Amin O, Kochilas LK. Long-term outcomes in single-ventricle congenital heart disease. Circulation. 2018;138:2718-2720.